PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WST vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WST and ABBV is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

WST vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in West Pharmaceutical Services, Inc. (WST) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
0.25%
5.06%
WST
ABBV

Key characteristics

Sharpe Ratio

WST:

-0.13

ABBV:

0.89

Sortino Ratio

WST:

0.09

ABBV:

1.22

Omega Ratio

WST:

1.01

ABBV:

1.20

Calmar Ratio

WST:

-0.12

ABBV:

1.11

Martin Ratio

WST:

-0.25

ABBV:

3.03

Ulcer Index

WST:

19.57%

ABBV:

6.99%

Daily Std Dev

WST:

38.73%

ABBV:

23.79%

Max Drawdown

WST:

-55.52%

ABBV:

-45.09%

Current Drawdown

WST:

-29.19%

ABBV:

-12.50%

Fundamentals

Market Cap

WST:

$24.21B

ABBV:

$309.92B

EPS

WST:

$6.75

ABBV:

$2.88

PE Ratio

WST:

49.52

ABBV:

60.90

PEG Ratio

WST:

6.24

ABBV:

0.42

Total Revenue (TTM)

WST:

$2.88B

ABBV:

$55.53B

Gross Profit (TTM)

WST:

$1.00B

ABBV:

$42.68B

EBITDA (TTM)

WST:

$743.90M

ABBV:

$24.24B

Returns By Period

In the year-to-date period, WST achieves a -5.66% return, which is significantly lower than ABBV's 19.33% return. Over the past 10 years, WST has outperformed ABBV with an annualized return of 20.49%, while ABBV has yielded a comparatively lower 14.99% annualized return.


WST

YTD

-5.66%

1M

3.28%

6M

-0.28%

1Y

-6.41%

5Y*

17.32%

10Y*

20.49%

ABBV

YTD

19.33%

1M

0.81%

6M

5.06%

1Y

19.35%

5Y*

19.78%

10Y*

14.99%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WST vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WST, currently valued at -0.16, compared to the broader market-4.00-2.000.002.00-0.160.89
The chart of Sortino ratio for WST, currently valued at 0.05, compared to the broader market-4.00-2.000.002.004.000.051.22
The chart of Omega ratio for WST, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.20
The chart of Calmar ratio for WST, currently valued at -0.15, compared to the broader market0.002.004.006.00-0.151.11
The chart of Martin ratio for WST, currently valued at -0.31, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.313.03
WST
ABBV

The current WST Sharpe Ratio is -0.13, which is lower than the ABBV Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of WST and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.16
0.89
WST
ABBV

Dividends

WST vs. ABBV - Dividend Comparison

WST's dividend yield for the trailing twelve months is around 0.24%, less than ABBV's 3.48% yield.


TTM20232022202120202019201820172016201520142013
WST
West Pharmaceutical Services, Inc.
0.24%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%
ABBV
AbbVie Inc.
3.48%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%3.03%

Drawdowns

WST vs. ABBV - Drawdown Comparison

The maximum WST drawdown since its inception was -55.52%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for WST and ABBV. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-29.19%
-12.50%
WST
ABBV

Volatility

WST vs. ABBV - Volatility Comparison

West Pharmaceutical Services, Inc. (WST) and AbbVie Inc. (ABBV) have volatilities of 6.22% and 6.53%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
6.22%
6.53%
WST
ABBV

Financials

WST vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab